The maximum price that patients should pay for drug eluting, bioresorbable vascular and biodegradable coronary stents was reduced to Rs 27,...

The drug pricing watchdog has threatened action against these hospitals, which were expected to make the revised prices available online so...

The move comes in the wake of various multinationals, including Abbott and Medtronic, seeking permission to withdraw some of their products...

Instances have come to the notice of NPPA that few companies dealing with coronary stents have come up with freebies by announcing schemes.

The instructions are being issued in public interest for compliance of ceiling prices by stent makers, distributors and hospitals, the NPPA...

The National Pharmaceutical Pricing Authority (NPPA) said the matter would end there for such hospitals if there were no further complaints.

These show cause notices have been sent after preliminary investigations into these allegations, the regulator disclosed on its official ac...

We have not overcharged even a single patient for stent. We have complied fully and immediately with the NPPA order on stent pricing, a Max...

The department of pharmaceutical has also invoked special provisions under the DPCO to ensure compliance with the pricing order as well as ...

In case of non-compliance of NPPA's instructions, the regulator said it may be constrained to invoke provisions of legal prosecution under ...

Last week, the government had slashed prices of stents by up to 85 per cent by capping them at Rs 7,260 for bare metal ones and Rs 29,600 f...

Following the NPPA decision, some companies have reportedly withdrawn high-priced stents, leading to an artificial shortage of the product.

"Price capping will make stents more affordable and accessible to patients and new prices leave enough margins to the industry to grow," he...

A cardiologist who spoke to ET on condition of anonymity said some companies, especially importers, have asked hospitals not to use stents ...

Cardiologists told TOI on Thursday the bioresorbable vascular scaffold (BVS)— the fourth generation and most recent one that dissolves into...

There are reports of shortages of stents in hospitals after the government reduced their prices by up to 85 per cent by capping rates of ba...

There have been reports of “artificial” shortage of stents since National Pharmaceutical Pricing Authority (NPPA) capped prices of these li...